Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > US nanotechnology leader joins DNT Board

December 15th, 2003

US nanotechnology leader joins DNT Board

Abstract:
Starpharma Pooled Development Limited is pleased to announce that Prof Jean Fréchet has joined the
Board of Dendritic Nanotechnologies, Inc. (DNT), the US nanotechnology company in which Starpharma has a 49.9% equity interest. Starpharma CEO Dr John Raff said: “Prof Fréchet has outstanding scientific credentials in addition to extensive experience and involvement in commercial and venture capital areas. His appointment to the Board of DNT complements other recent high profile commercial appointments, and further consolidates DNT as a significant participant in the US nanotechnology industry." (PDF)

Source:
SPL

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project